METHOD OF NON-SMALL CELL LUNG CARCINOMA DIAGNOSTICS AND RELATED ANALYSIS SET

FIELD: medicine; oncology; molecular biology. ^ SUBSTANCE: to diagnose non-small cell lung carcinoma potentially cancer-affected human tissue and adjacent histologically normal tissue are tested for gene WIF1 transcription level. Lowered transcription level detected in potentially cancer-affected hu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SVERDLOV EVGENIJ DAVIDOVICH, KOROBKO ELENA VLADIMIROVNA, VINOGRADOVA TAT'JANA VIKTOROVNA, ZBOROVSKAJA IRINA BORISOVNA, KOPANTSEV EVGENIJ PAVLOVICH, GEORGIEV GEORGIJ PAVLOVICH, KOROBKO IGOR' VIKTOROVICH, ZINOV'EVA MARINA VALER'EVNA
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine; oncology; molecular biology. ^ SUBSTANCE: to diagnose non-small cell lung carcinoma potentially cancer-affected human tissue and adjacent histologically normal tissue are tested for gene WIF1 transcription level. Lowered transcription level detected in potentially cancer-affected human tissue compared to that of adjacent histologically normal tissue is diagnostic indicator of non-small cell lung carcinoma. For realisation of polymerase chain reaction within detection of gene WIF1 transcription level, primers set of sequence SEQ ID NO: 1 and 2 is used. ^ EFFECT: invention application provides high-reliable diagnostics of non-small cell lung carcinoma, including squamous cell carcinoma, as well as at earliest stage of tumour transformation progression. ^ 8 cl, 2 dwg, 1 tbl, 6 ex